Dementia Drugs Market
Global Dementia Drugs Market Size, Share & Trends Analysis Report By Type of Dementia (Lewy Body Dementia, Parkinson’s Disease, Alzheimer's Disease, and Others), By Type of Drug (Cholinesterase Inhibitors, MAO Inhibitors, Glutamate Inhibitors, and Others), and Forecast 2022-2028
The global dementia drugs market is anticipated to grow at a significant CAGR of around 8.1% during the forecast period. Dementia is a neurological condition that affects the brain functionality generally more than two functions. Hence, dementia can be correlated with other neurological conditions such as Parkinson’s disease, Alzheimer’s disease, and many more. The factors such as increasing cases of associated conditions of dementia will directly impact the growth of the dementia market during the forecast period. However, the low awareness regarding the dementia condition in developing turns out to be a restraint for the growth of the dementia drugs market. Additionally, the low diagnosis rate will also hamper the growth of the dementia drug market during the forecast period. Moreover, the side effects of dementia drugs such as nausea, vomiting, loss of appetite, sleep problems, feeling of tiredness will lower the popularity of these drugs in the dementia drug market. However, the increasing research for the drug development of dementia as well as its associated conditions will present new growth opportunities to the dementia drug market during the forecast period.
Impact of COVID-19 on the global dementia drugs market
The outbreak of the COVID-19 pandemic is expected to have a considerable impact on the dementia drugs market. In January 2021, the population with dementia is at high risk of contracting COVID-19 infection as the cognitive symptoms cause difficulty to abide by the safety guidelines that were proposed to contain the viral spread.
Segmental Outlook
The global dementia drugs market is segmented based on the type of dementia and type of drugs. Based on the type of dementia, the market is sub-segmented into lewy body dementia, parkinson's disease dementia, alzheimer's disease dementia, and others such as vascular dementia. Further based on the type of drugs, the market is sub-segmented into cholinesterase inhibitors, MAO inhibitors, glutamate inhibitors, and others.
Global Dementia Drugs Market by Drug Class, 2021 (%)
Alzheimer’s Disease Dementia is anticipated to have a major share in the global dementia drugs market
Alzheimer’s disease segment is anticipated to have a major share in the market due to the major factors such as the increasing burden of Alzheimer’s disease and ongoing research and development for Alzheimer’s. For instance, as per the Alzheimer’s Association 2021 report, the United States Food and Drug Administration (FDA) has approved five drugs for the treatment of Alzheimer’s, namely rivastigmine, galantamine, donepezil, memantine, and memantine combined with donepezil. The majority of the people who are 65 or older develop Alzheimer’s dementia. For instance, in Act 2020, the third dementia innovation readiness index was launched by Alzheimer’s Diseases International in partnership with the Lien Foundation and Global Coalition on Aging (GCOA) in 30 global cities across the globe.
Regional Outlooks
The global saffron tablets market is further segmented based on geography including North America (the US and Canada), Europe (Italy, Spain, Germany, France, Rest of Europe), Asia Pacific (India, China, Japan, South Korea, Rest of Asia Pacific), and the Rest of the World (Latin America and the Middle East and Africa). North America is expected to hold the largest market share in the dementia drugs during the forecast period. The growth of the region is owing to the well-developed healthcare structure in the region. Additionally, the increasing number of patients diagnosed with dementia as well as its associated condition such as Parkinson’s disease will also fuel the dementia drugs market growth across the region.
Global Dementia Drugs Market Growth by Region, 2022-2028
The European region is estimated to hold the major share in the Global Dementia Market
Europe is anticipated to exhibit a considerable growth rate in the dementia drugs market owing to the increasing geriatric population across the region. The major factors that are driving the market growth in the region are the increasing numbers of neurological disorders in countries such as the United Kingdom and Germany, the growth in strategic development by the market players operating in the industry, and increasing government initiatives. The origin of dementia in the geriatric population is highest and hence increasing the geriatric population represents a huge population pool of dementia.
Market Players Outlook
Some of the key players operating in the global dementia drugs market include Teva Pharmaceuticals Industries Ltd., Merck & Co. Inc., Pfizer Inc., GlaxoSmithKline Plc, Aurobindo Pharma Ltd., Biogen Inc., and others. The market players are considerably contributing to the market growth by adopting various strategies including new product launches, mergers, and acquisitions, collaborations with the government, and new drug commercialization to stay competitive in the market. For instance, in July 2020 Eisai Pharmaceuticals India Pvt Ltd, Co-developed and began the provision of the brain application as a strategy towards the preparation against dementia based on an alliance agreement with DeSC Healthcare. Inc. This was carried out to expand the treatment options and gain a competitive advantage.
The report covers
- Market value data analysis of 2022 and forecast to 2028
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global dementia drugs market.
- Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market
1. Report Summary
• Current Industry Analysis and Growth Potential Outlook
• Impact of COVID-19 on the Global Dementia Drugs Market
1.1. Recovery Scenario of Global Dementia Drugs Market
1.2. Research Methods and Tools
1.3. Market Breakdown
1.3.1. By Segments
1.3.2. BY Region
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
3. Competitive Landscape
3.1. Pfizer Inc
3.1.1. Overview
3.1.2. Financial Analysis
3.1.3. SWOT Analysis
3.1.4. Recent Developments
3.2. Teva Pharmaceuticals Industries Ltd
3.2.1. Overview
3.2.2. Financial Analysis
3.2.3. SWOT Analysis
3.2.4. Recent Developments
3.3. Merck & Co Inc
3.3.1. Overview
3.3.2. Financial Analysis
3.3.3. SWOT Analysis
3.3.4. Recent Developments
3.4. GlaxoSmithKline Plc
3.4.1. Overview
3.4.2. Financial Analysis
3.4.3. SWOT Analysis
3.4.4. Recent Developments
3.5. Cadila Healthcare Ltd
3.5.1. Overview
3.5.2. Financial Analysis
3.5.3. SWOT Analysis
3.5.4. Recent Developments
3.6. Key Strategy Analysis
3.7. Impact of Covid-19 on Key Players
4. Market Segmentation
Global Dementia Drugs Market by Dementia Type
4.1.1. Lewy Body Dementia
4.1.2. Parkison’s Disease Dementia
4.1.3. Alzheimer’s Disease Dementia
4.1.4. Others
Global Dementia Drugs Market by Drugs Type
4.1.5. Cholinesterase Inhibitors
4.1.6. MAO Inhibitors
4.1.7. GlutamateInhibitors
4.1.8. Others
5. Regional Analysis
5.1. North America
5.1.1. United States
5.1.2. Canada
5.2. Europe
5.2.1. UK
5.2.2. Germany
5.2.3. Italy
5.2.4. Spain
5.2.5. France
5.2.6. Rest of Europe
5.3. Asia-Pacific
5.3.1. China
5.3.2. India
5.3.3. Japan
5.3.4. South Korea
5.3.5. Rest of Asia-Pacific
5.4. Rest of the World
5.4.1 Latin America
5.4.2 Middle East and Africa
6. Company Profiles
6.1. Abbvie Inc
6.2. ACADIA Pharmaceutical Inc
6.3. Apotex Corp
6.4. Aurobindo Pharma Ltd
6.5. Biogen Inc
6.6. GlaxoSmithKline Plc
6.7. Johnson & Johnson Services, Inc
6.8. Merck & Co Inc
6.9. Mylan Nv
6.10. Novartis International AG
6.11. Pfizer Inc
6.12. Teva Pharmaceutical Industries Ltd
1. GLOBAL DEMENTIA DRUGS MARKET RESEARCH AND ANALYSIS BY DEMENTIA TYPE OF DEMENTIA, 2021-2028 ($ MILLION)
2. GLOBAL LEWY BODY DEMENTIA DRUGS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
3. GLOBAL PARKINSONS DISEASE DEMENTIA DRUGS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
4. GLOBAL ALZHEIMERS DISEASE DEMENTIA DRUGS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
5. GLOBAL OTHERS DEMENTIA DRUGS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
6. GLOBAL DEMENTIA DRUGS MARKET RESEARCH AND ANALYSIS BY DRUG, 2021-2028 ($ MILLION)
7. GLOBAL CHOLINESTERASE INHIBITORS IN DEMENTIA DRUGS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
8. GLOBAL MAO INHIBITORS IN DEMENTIA DRUGS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
9. GLOBAL GLUTAMATE INHIBITORS IN DEMENTIA DRUGS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
10. GLOBAL OTHERS DEMENTIA DRUGS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
11. GLOBAL DEMENTIA DRUGS MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2021-2028 ($ MILLION)
12. NORTH AMERICAN DEMENTIA DRUGS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
13. NORTH AMERICAN DEMENTIA DRUGS MARKET RESEARCH AND ANALYSIS BY TYPE OF DEMENTIA, 2021-2028 ($ MILLION)
14. NORTH AMERICAN DEMENTIA DRUGS MARKET RESEARCH AND ANALYSIS BY TYPE OF DRUG 2021-2028 ($ MILLION)
15. EUROPEAN DEMENTIA DRUGS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
16. EUROPEAN DEMENTIA DRUGS MARKET RESEARCH AND ANALYSIS BY TYPE OF DEMENTIA, 2021-2028 ($ MILLION)
17. EUROPEAN DEMENTIA DRUGS MARKET RESEARCH AND ANALYSIS BY TYPE OF DRUG, 2021-2028 ($ MILLION)
18. ASIA-PACIFIC DEMENTIA DRUGS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
19. ASIA-PACIFIC DEMENTIA DRUGS MARKET RESEARCH AND ANALYSIS BY TYPE OF DEMENTIA, 2021-2028 ($ MILLION)
20. ASIA-PACIFIC DEMENTIA DRUGS MARKET RESEARCH AND ANALYSIS BY TYPE OF DRUG, 2021-2028 ($ MILLION)
21. REST OF THE WORLD DEMENTIA DRUGS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
22. REST OF THE WORLD DEMENTIA DRUGS MARKET RESEARCH AND ANALYSIS BY TYPE OF DEMENTIA, 2021-2028 ($ MILLION)
23. REST OF THE WORLD DEMENTIA DRUGS MARKET RESEARCH AND ANALYSIS BY TYPE OF DRUG, 2021-2028 ($ MILLION)
1. IMPACT OF COVID-19 ON GLOBAL DEMENTIA DRUG MARKET, 2021-2028 ($ MILLION)
2. IMPACT OF COVID-19 ON GLOBAL DEMENTIA DRUGS MARKET BY SEGMENT, 2021-2028 ($ MILLION)
3. RECOVERY OF GLOBAL DEMENTIA DRUGS MARKET, 2021-2028 (%)
4. GLOBAL DEMENTIA DRUGS MARKET SHARE BY DEMANTIA TYPE, 2021 VS 2028 (%)
5. GLOBAL LEWY BODY DEMENTIA DRUGS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
6. GLOBAL PARKINSONS DISEASE DEMENTIA DRUGS MARKET SHARE BY GEOGRAPHY, 2021-2028 ($ MILLION)
7. GLOBAL ALZHEIMERS DISEASE DEMENTIA DRUGS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
8. GLOBAL OTHERS DEMENTIA DRUGS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
9. GLOBAL DEMENTIA DRUGS MARKET RESEARCH AND ANALYSIS BY DRUG TYPE, 2021 VS 2028 (%)
10. GLOBAL CHOLINESTERASE INHIBITORS DEMENTIA DRUGS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
11. GLOBAL MAO INHIBITORS DEMENTIA DRUGS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
12. GLOBAL GLUTAMATE INHIBITORS DEMENTIA DRUGS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
13. GLOBAL OTHERS DEMENTIA DRUGS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
14. GLOBAL DEMENTIA DRUGS MARKET SHARE BY GEOGRAPHY, 2021-2028 ($ MILLION)
15. US DEMENTIA DRUGS MARKET SIZE, 2021-2028 ($ MILLION)
16. CANADA DEMENTIA DRUGS MARKET SIZE, 2021-2028 ($ MILLION)
17. UK DEMENTIA DRUGS MARKET SIZE, 2021-2028 ($ MILLION)
18. FRANCE DEMENTIA DRUGS MARKET SIZE, 2021-2028 ($ MILLION)
19. GERMANY DEMENTIA DRUGS MARKET SIZE, 2021-2028 ($ MILLION)
20. ITALY DEMENTIA DRUGS MARKET SIZE, 2021-2028 ($ MILLION)
21. SPAIN DEMENTIA DRUGS MARKET SIZE, 2021-2028 ($ MILLION)
22. REST OF EUROPE DEMENTIA DRUGS MARKET SIZE, 2021-2028 ($ MILLION)
23. INDIA DEMENTIA DRUGS MARKET SIZE, 2021-2028 ($ MILLION)
24. CHINA DEMENTIA DRUGS MARKET SIZE, 2021-2028 ($ MILLION)
25. JAPAN DEMENTIA DRUGS MARKET SIZE, 2021-2028 ($ MILLION)
26. SOUTH KOREA DEMENTIA DRUGS MARKET SIZE, 2021-2028 ($ MILLION)
27. REST OF ASIA-PACIFIC DEMENTIA DRUGS MARKET SIZE, 2021-2028 ($ MILLION)
28. REST OF THE WORLD DEMENTIA DRUGS MARKET SIZE, 2021-2028 ($ MILLION)
